logo

(1) SYRUP SUCRALFATE 1 GM + OXETACAINE 20 MG/5ML 200 ML BOTTLE. (2) TAB/CAP TOFACITINIB 11 MG. (3) TAB/CAP TEMOZOLAMIDE 100 MG. (4) TAB/CAP TEMOZOLAMIDE 250 MG. (5) TAB/CAP UPADACITINIB 15 MG./97265870B/107200511

The scope, dates and status of this tender. A free account opens every field.

Tender
Active

(1) SYRUP SUCRALFATE 1 GM + OXETACAINE 20 MG/5ML 200 ML BOTTLE. (2) TAB/CAP TOFACITINIB 11 MG. (3) TAB/CAP TEMOZOLAMIDE 100 MG. (4) TAB/CAP TEMOZOLAMIDE 250 MG. (5) TAB/CAP UPADACITINIB 15 MG.

Status
Bidding
Sector
Rail, Government
Location
India
Updated
3 Nov 2026
Source
Government e-MarketPlace, Central Public Procurement Portal, India

ConstructChat

Ask ConstructChat about (1) SYRUP SUCRALFATE 1 GM + OXETACAINE 20 MG/5ML 200 ML BOTTLE. (2) TAB/CAP TOFACITINIB 11 MG. (3) TAB/CAP TEMOZOLAMIDE 100 MG. (4) TAB/CAP TEMOZOLAMIDE 250 MG. (5) TAB/CAP UPADACITINIB 15 MG./97265870B/107200511

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Tender Information FAQ

Tender Information

3 Q
The tender “(1) SYRUP SUCRALFATE 1 GM + OXETACAINE 20 MG/5ML 200 ML BOTTLE. (2) TAB/CAP TOFACITINIB 11 MG. (3) TAB/CAP TEMOZOLAMIDE 100 MG. (4) TAB/CAP TEMOZOLAMIDE 250 MG. (5) TAB/CAP UPADACITINIB 15 MG./97265870B/107200511” is a tender record in Taiyo, linked to the Rail sector. It is issued for works, goods, or services related to India.

Participants

Not available for this record.

Status

Original status

active

Taiyo status

Bidding

Taiyo last update

2026-11-03

Contact

Not available for this record.

Description

Description

(1) SYRUP SUCRALFATE 1 GM + OXETACAINE 20 MG/5ML 200 ML BOTTLE. (2) TAB/CAP TOFACITINIB 11 MG. (3) TAB/CAP TEMOZOLAMIDE 100 MG. (4) TAB/CAP TEMOZOLAMIDE 250 MG. (5) TAB/CAP UPADACITINIB 15 MG.

Location

Country

India

Source

Source

Government e-MarketPlace, Central Public Procurement Portal, India

URL

More Details

Record type

Tender

Sector

Rail, Government

Article published date

2026-10-10

More on this tender

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this tender
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this tender